User:Mr. Ibrahem/Nusinersen

Nusinersen, sold under the brand name Spinraza, is a medication used to treat spinal muscular atrophy (SMA). It improves motor function. It is given by injection into the spinal canal.

Common side effects include respiratory infection, constipation, and ear infection. Other side effects include low platelets, bleeding, and kidney problems. Safety in pregnancy is unclear. It is an antisense oligonucleotide which increases survival motor neuron.

Nusinersen was approved for medical use in the United States in 2016 and Europe in 2017. In the United Kingdom it costs about £75,000 a dose as of 2021. In the United States this amount costs about 133,000 USD.